Rupal Tripathi

机构：Rajiv Gandhi Cancer Institute and Research Centre · ORCID：0000-0003-2007-2450

发表论文 49 篇 · 总被引 275 次 · h-index 10

代表论文

• Systems biology drug screening identifies statins as enhancers of current therapies in chronic lymphocytic leukemia (2020 · Scientific Reports · 被引 31)
• Prognostic role of microRNA 182 and microRNA 18a in locally advanced triple negative breast cancer (2020 · PLoS ONE · 被引 22)
• SF3B1 mutation–mediated sensitization to H3B-8800 splicing inhibitor in chronic lymphocytic leukemia (2023 · Life Science Alliance · 被引 18)
• Multicentric real world evidence with palbociclib in hormone positive HER2 negative metastatic breast cancer in Indian population (2021 · Scientific Reports · 被引 15)
• SMARCA4/BRG1 protein-deficient thoracic tumors dictate re-examination of small biopsy reporting in non–small cell lung cancer (2021 · Journal of Pathology and Translational Medicine · 被引 10)
• Role of Circulating Tumor Cells in Determining Prognosis in Metastatic Breast Cancer (2022 · South Asian Journal of Cancer · 被引 5)